Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial. (2020)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(20)30189-2
PubMed Identifier: 32763217
Publication URI: http://europepmc.org/abstract/MED/32763217
Type: Journal Article/Review
Volume: 7
Parent Publication: The lancet. HIV
Issue: 8
ISSN: 2352-3018